EP 1408991 A4 20040421 - NASAL SPRAY HAVING DEAD SEA SALTS
Title (en)
NASAL SPRAY HAVING DEAD SEA SALTS
Title (de)
AUF TOTE SEE SALZEN BASIERTE NASENSPRAY
Title (fr)
AEROSOL NASAL A BASE DE SELS DE LA MER MORTE
Publication
Application
Priority
- US 0018012 W 20000630
- US 34504399 A 19990630
Abstract (en)
[origin: WO0100218A1] A nasal spray formulation for use with the treatment of rhinitis, sinusitis, epistaxis and post-surgical irrigation. The nasal spray formulation includes the Dead Sea salt or its equivalent. The composition of the Dead Sea salt mixture includes about 31-35 % magnesium halide, about 24-26 % potassium halide, about 4-8 % sodium halide, about 0.4-0.6 % calcium halide, the halide being about 0.3-0.6 % bromide, about 99.4-99.7 % chloride, and may also include about 0.05-0.2 % sulphates, about 0.5-0.2 % insolubles. The salts may comprise about 34-38 % water of crystallization. The spray formulation is about 0.5 to about 5 grams per liter of sterile aqueous solution, contains a buffer, and is essentially free of noxious, organic impurities.
IPC 1-7
IPC 8 full level
A61K 33/00 (2006.01); A61K 33/06 (2006.01); A61K 33/14 (2006.01)
CPC (source: EP)
A61K 33/14 (2013.01)
C-Set (source: EP)
Citation (search report)
- [PA] EP 0937453 A2 19990825 - SCHWARTZ SAM [US]
- [X] MULLER-SACKS E ET AL: "Sea salt containing nose spray in rhinitis sicca. Results of an observational study", DEUTSCHE APOTHEKER ZEITUNG 14 MAY 1998 GERMANY, vol. 138, no. 20, 14 May 1998 (1998-05-14), pages 73 - 76, XP001157161, ISSN: 0011-9857
- See references of WO 0100218A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0100218 A1 20010104; AU 5901700 A 20010131; CA 2377088 A1 20010104; EP 1408991 A1 20040421; EP 1408991 A4 20040421
DOCDB simple family (application)
US 0018012 W 20000630; AU 5901700 A 20000630; CA 2377088 A 20000630; EP 00945017 A 20000630